Wells Fargo’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130M | Buy |
3,051,613
+80,291
| +3% | +$4.36M | 0.02% | 567 |
|
|
2026
Q1 | $186M | Sell |
2,971,322
-1,165,706
| -28% | -$93.3M | 0.04% | 412 |
|
|
2025
Q4 | $394M | Sell |
4,137,028
-22,207
| -0.5% | -$2.18M | 0.07% | 234 |
|
|
2025
Q3 | $406M | Buy |
4,159,235
+451,147
| +12% | +$46.7M | 0.08% | 223 |
|
|
2025
Q2 | $398M | Buy |
3,708,088
+149,530
| +4% | +$15.1M | 0.08% | 218 |
|
|
2025
Q1 | $359M | Buy |
3,558,558
+366,749
| +11% | +$36.9M | 0.08% | 226 |
|
|
2024
Q4 | $285M | Buy |
3,191,809
+83,431
| +3% | +$7.34M | 0.06% | 260 |
|
|
2024
Q3 | $260M | Sell |
3,108,378
-47,109
| -1% | -$3.71M | 0.06% | 269 |
|
|
2024
Q2 | $243M | Sell |
3,155,487
-38,217
| -1% | -$2.8M | 0.06% | 272 |
|
|
2024
Q1 | $219M | Buy |
3,193,704
+396,799
| +14% | +$25.5M | 0.05% | 290 |
|
|
2023
Q4 | $162M | Sell |
2,796,905
-155,845
| -5% | -$8.32M | 0.04% | 340 |
|
|
2023
Q3 | $156M | Sell |
2,952,750
-430,998
| -13% | -$22.6M | 0.05% | 316 |
|
|
2023
Q2 | $183M | Sell |
3,383,748
-136,719
| -4% | -$7.14M | 0.05% | 292 |
|
|
2023
Q1 | $176M | Sell |
3,520,467
-193,368
| -5% | -$9.11M | 0.05% | 300 |
|
|
2022
Q4 | $172M | Sell |
3,713,835
-32,856
| -0.9% | -$1.42M | 0.05% | 306 |
|
|
2022
Q3 | $145M | Sell |
3,746,691
-2,470
| -0.1% | -$99.1K | 0.05% | 318 |
|
|
2022
Q2 | $140M | Sell |
3,749,161
-835,614
| -18% | -$34M | 0.04% | 336 |
|
|
2022
Q1 | $203M | Buy |
4,584,775
+669,036
| +17% | +$29M | 0.05% | 295 |
|
|
2021
Q4 | $166M | Sell |
3,915,739
-3,944,533
| -50% | -$166M | 0.04% | 336 |
|
|
2021
Q3 | $341M | Buy |
7,860,272
+348,398
| +5% | +$15.4M | 0.07% | 250 |
|
|
2021
Q2 | $321M | Buy |
7,511,874
+451,146
| +6% | +$19M | 0.07% | 265 |
|
|
2021
Q1 | $273M | Sell |
7,060,728
-1,588,179
| -18% | -$60.1M | 0.06% | 308 |
|
|
2020
Q4 | $311M | Sell |
8,648,907
-2,494,701
| -22% | -$89.9M | 0.07% | 255 |
|
|
2020
Q3 | $426M | Sell |
11,143,608
-204,107
| -2% | -$7.87M | 0.12% | 170 |
|
|
2020
Q2 | $398M | Sell |
11,347,715
-1,193,032
| -10% | -$43M | 0.12% | 174 |
|
|
2020
Q1 | $409M | Buy |
12,540,747
+1,646,596
| +15% | +$64.3M | 0.14% | 153 |
|
|
2019
Q4 | $493M | Sell |
10,894,151
-317,188
| -3% | -$13.3M | 0.13% | 154 |
|
|
2019
Q3 | $456M | Buy |
11,211,339
+304,891
| +3% | +$12.9M | 0.13% | 157 |
|
|
2019
Q2 | $469M | Sell |
10,906,448
-65,001
| -0.6% | -$2.5M | 0.13% | 154 |
|
|
2019
Q1 | $421M | Buy |
10,971,449
+66,983
| +0.6% | +$2.56M | 0.13% | 163 |
|
|
2018
Q4 | $385M | Sell |
10,904,466
-116,830
| -1% | -$4.24M | 0.13% | 158 |
|
|
2018
Q3 | $424M | Sell |
11,021,296
-796,346
| -7% | -$27.8M | 0.12% | 168 |
|
|
2018
Q2 | $386M | Sell |
11,817,642
-912,854
| -7% | -$27.5M | 0.11% | 181 |
|
|
2018
Q1 | $348M | Buy |
12,730,496
+784,825
| +7% | +$21.3M | 0.1% | 201 |
|
|
2017
Q4 | $296M | Buy |
11,945,671
+2,705,194
| +29% | +$74.6M | 0.09% | 237 |
|
|
2017
Q3 | $270M | Buy |
9,240,477
+82,709
| +0.9% | +$2.28M | 0.08% | 245 |
|
|
2017
Q2 | $254M | Buy |
9,157,768
+867,983
| +10% | +$23M | 0.08% | 251 |
|
|
2017
Q1 | $206M | Buy |
8,289,785
+200,190
| +2% | +$4.87M | 0.07% | 296 |
|
|
2016
Q4 | $175M | Buy |
8,089,595
+1,273,355
| +19% | +$27.8M | 0.06% | 323 |
|
|
2016
Q3 | $162M | Buy |
6,816,240
+550,336
| +9% | +$13.1M | 0.06% | 340 |
|
|
2016
Q2 | $146M | Buy |
6,265,904
+138,162
| +2% | +$2.99M | 0.06% | 362 |
|
|
2016
Q1 | $115M | Buy |
6,127,742
+2,825,011
| +86% | +$49.6M | 0.05% | 417 |
|
|
2015
Q4 | $60.9M | Buy |
3,302,731
+260,006
| +9% | +$4.66M | 0.02% | 666 |
|
|
2015
Q3 | $49.9M | Buy |
3,042,725
+346,140
| +13% | +$5.92M | 0.02% | 745 |
|
|
2015
Q2 | $47.7M | Buy |
2,696,585
+863,307
| +47% | +$15.4M | 0.02% | 831 |
|
|
2015
Q1 | $32.5M | Buy |
1,833,278
+26,345
| +1% | +$416K | 0.01% | 1032 |
|
|
2014
Q4 | $23.9M | Sell |
1,806,933
-1,802,107
| -50% | -$23M | 0.01% | 1169 |
|
|
2014
Q3 | $42.6M | Sell |
3,609,040
-340,274
| -9% | -$4.29M | 0.02% | 827 |
|
|
2014
Q2 | $50.4M | Sell |
3,949,314
-14,045,198
| -78% | -$183M | 0.02% | 769 |
|
|
2014
Q1 | $243M | Sell |
17,994,512
-2,082,199
| -10% | -$27.3M | 0.1% | 239 |
|
|
2013
Q4 | $241M | Buy |
20,076,711
+8,927,050
| +80% | +$105M | 0.1% | 240 |
|
|
2013
Q3 | $131M | Buy |
11,149,661
+7,721,043
| +225% | +$83.5M | 0.06% | 352 |
|
|
2013
Q2 | $31.8M | Buy |
+3,428,618
| New | +$29.1M | 0.02% | 869 |
|
Other funds holding BSX
Wells Fargo's BSX Position: Q2 2026 in Review
Wells Fargo increased its Boston Scientific (BSX) stake by 2.7% in Q2 2026, buying an estimated $4.36M and bringing the position to 3,051,613 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #567.
Wells Fargo first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $493M in Q4 2019. 1,473 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Wells Fargo held 3,051,613 shares of Boston Scientific worth $130M as of Q2 2026.
- Wells Fargo bought 80,291 Boston Scientific shares in Q2 2026, an estimated $4.36M.
- Boston Scientific made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #567 holding.
- Wells Fargo first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Boston Scientific position peaked at $493M in Q4 2019.
- 1,473 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.